Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form‐36, and other patient‐reported outcomes
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17629 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Shinichi Imafuku und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, Fukuoka University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Psoriasis, Quality of Life. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Nippon Boehringer Ingelheim, Boehringer Ingelheim Japan.
Abstract (Originalsprache)
Generalized pustular psoriasis is a rare but severe form of psoriasis, accounting for 7.5% of all psoriasis cases. We investigated whether the disease burden and quality of life of patients with generalized pustular psoriasis were lower than those of patients with psoriasis vulgaris in Japan. Patients registered in the Western Japan Psoriasis Registry, a prospective cohort of patients with psoriasis treated at 31 facilities specializing in psoriasis medicine, were surveyed using the SF‐36v2 and other patient‐reported outcomes. We enrolled patients with generalized pustular psoriasis ( n = 97) and psoriasis vulgaris ( n = 1065). The generalized pustular psoriasis group had fewer males, were younger at onset, had fewer smokers and habitual drinkers, and were more frequently treated with biologics than patients with psoriasis vulgaris. Questions on disease burden revealed that patients with generalized pustular psoriasis experienced sores, blisters, skin pain, and systemic symptoms more frequently than patients with psoriasis vulgaris. A higher proportion of patients with generalized pustular psoriasis had joint pain and fatigue than those with psoriasis vulgaris, although patient satisfaction with treatment did not differ significantly between the two groups. The Short Form‐36 evaluation revealed that patients with generalized pustular psoriasis had significantly lower physical component summary scores than patients with psoriasis vulgaris. These findings indicate that patients with generalized pustular psoriasis have a higher burden and more impaired quality of life than patients with psoriasis vulgaris.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, Fukuoka University, Fukuoka, Japan.
- Department of Preventive Medicine & Public Health, School of Medicine, Fukuoka University, Fukuoka, Japan.
- Division of Dermatology, Kitakyushu Yahata Hospital, Fukuoka, Japan.
- Nippon Boehringer Ingelheim, Tokyo, Japan.
ORCID-Profile: Shinichi Imafuku, Noriko Tsuruta
Förderung
- Nippon Boehringer Ingelheim
- Boehringer Ingelheim Japan
Zitieren
APA
Imafuku, S., Satoh, A., Arima, H., Tsuruta, N., Iwasaki, R., Kimura, H., & Western Japan Inflammatory Skin Disease Research Group (2025). Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form‐36, and other patient‐reported outcomes. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17629
Vancouver
Imafuku S, Satoh A, Arima H, Tsuruta N, Iwasaki R, Kimura H, et al. Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form‐36, and other patient‐reported outcomes. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17629
BibTeX
@article{Imafuku2025,
author = {Imafuku, Shinichi and Satoh, Atsushi and Arima, Hisatomi and Tsuruta, Noriko and Iwasaki, Ryoko and Kimura, Hana and Western Japan Inflammatory Skin Disease Research Group, Western Japan Inflammatory Skin Disease Research Group},
title = {Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form‐36, and other patient‐reported outcomes},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17629}
}
EUVIMED